By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The University of Southern California’s Keck School of Medicine has landed a $24 million gift from media mogul Sumner Redstone to fund molecular research into prostate cancer, USC said this week.

The research will involve genomics and proteomics and will be led by David Agus, who is director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center and a co-founder of Navigenics, the Keck School of Medicine said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.